Bioxyne Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioxyne Limited with three other
companies in this sector in AUSTRALIA :
Amplia Therapeutics Ltd
sales of 1.53 million Australian Dollars [US$1.11 million]
Zelira Therapeutics Ltd
(2.09 million Australian Dollars [US$1.52 million]
of which 27%
was USA), and
(2.33 million Australian Dollars [US$1.69 million]
of which 100%
was Drug Development).
During the year ended June of 2021, sales at
Bioxyne Limited were A$2.11 million (US$1.53 million).
decrease of 6.6%
versus 2020, when the company's sales were A$2.26 million.
The sales level in 2021 was fairly close to the level five years ago: in 2016, Bioxyne Limited had sales
of A$1.92 million.